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Figure	1:	Diagram	of	typical	Notch	signal	transduction	in	nematodes		
Introduction			 The	cell	signaling	pathways	mediated	by	Notch	and	Epidermal	Growth	Factor	(EGF)	are	critical	pathways	found	across	the	entire	animal	kingdom	(Artavanis-Tsakonas	et	al.,	1999).		Mutations	and	errors	causing	disruptions	in	these	two	pathways	have	been	connected	with	a	variety	of	cancers	(Galluzzo	and	Bocchetta,	2011).		Depending	on	the	tissue	type,	the	same	Notch	and	EGF	components	can	function	either	as	oncogenes	or	tumor	suppressors	(Espinoza	and	Miele,	2013).		To	better	understand	the	functioning	of	the	two	pathways	and	the	manner	in	which	they	interact,	research	on	basic	model	organisms	like	the	nematode	is	needed.		This	can	provide	insight	into	the	differential	functioning	of	the	two	pathways	based	on	cellular	background.		 The	Notch	signal	transduction	pathway	operates	through	a	ligand/receptor	interaction	between	two	cells.		In	nematodes,	the	“DSL”	ligand	of	LAG-2	or	APX-1	released	by	one	cell	will	interact	with	the	LIN-12	transmembrane	receptor	on	the	target	cell	to	cause	a	cleavage	of	the	extracellular	domain.		This	will	lead	to	a	further	cleavage	of	LIN-12	in	the	transmembrane	portion	that	leads	to	its	release.		The	intracellular	portion	will	then	drop	into	the	nucleus	and	form	a	complex	with	SEL-8	and	LAG-1.		Normally,	LAG-1	acts	as	a	repressor	of	the	target	gene	but	the	formation	of	the	complex	allows	it	to	induce	DNA	transcription	(Petcherski	and	Kimble,	2000).			In	nematodes,	EGF	signaling	involves	the	ligand	LIN-3	binding	to	a	receptor	tyrosine	kinase	such	as	LET-23	which	leads	to	the	activation	of	the	RAS	ortholog	LET-60.		This	causes	a	phosphorylation	cascade	and	transcription	of	a	target	gene	through	transcription	factors	such	as	LIN-31	(Yamamoto	et	al.,	2014).		The	EGF	and	Notch	pathway	have	been	shown	to	cooperate	and	antagonize	each	other	in	nematodes	as	well	as	in	other	species.		During	the	development	of	the	Drosophila	eye,	high	Notch	activity	and	low	EGF	levels	are	both	required	for	early	photoreceptors	to	progress	past	the	G1	phase	and	continue	dividing	(Baker	and	Yu,	2001).		In	the	same	environment	the	two	pathways	also	work	together	to	stimulate	cone	cell	formation.		Both	are	needed	at	high	levels	to	promote	specific	transcription	factor	activity	(Flores	et	al.,	2000).		Notch	and	EGF	have	been	shown	to	antagonize	each	other	in	the	Drosophila	eye,	as	well	as	in	species	like	the	zebrafish	where	Ras-activated	factors	will	antagonize	Notch-induced	factors	if	both	are	present	(Kawamura	et	al.,	2005).	Additionally,	microarray-based	transcriptome	analysis	in	Drosophila	has	
shown	that	65%	of	transcriptional	targets	are	shared	between	the	two	pathways	(Guruharsha	et	al.,	2012).	This	project	focused	on	the	nematode	vulva,	and	both	signaling	pathways	must	interact	in	the	proper	way	in	order	to	let	the	vulva	form	correctly.		However,	this	experiment	dealt	with	disruption	of	the	Notch	pathway	to	observe	effects	on	vulval	development.				 Caenorhabditis	elegans	and	Caenorhabditis	briggsae	were	the	subjects	used	in	this	project.		Both	are	nematodes	that	have	their	genomes	sequenced	and	mapped;	in	the	case	of	elegans	the	entire	cell	lineage	determined	(Giurumescu	and	Chisholm,	2011).			The	two	species	diverged	from	each	other	about	30	million	years	ago,	yet	about	62%	of	genes	have	a	direct	ortholog	found	in	the	other	(Gupta	and	Sternberg,	2003;	Cutter,	2008).		Both	species	have	a	similar	genome	size	(102	Mb	for	elegans	and	104	Mb	for	briggsae)	and	six	chromosomes.		Additionally,	the	development	of	the	vulva	is	conserved	and	occurs	in	a	very	similar	way	at	a	cellular	level	(Horvitz	and	Sternberg,	1991).	Despite	the	large	amount	of	genes	without	a	direct	ortholog	found	between	the	two	species,	elegans	and	briggsae	are	near	identical	in	respect	to	morphology	and	behavior.			One	area	where	the	two	differ	greatly	is	in	vulva	formation.		While	normal	vulval	development	is	identical	in	the	two	species	in	cells,	experimental	results	argue	that	both	exhibit	biochemical	differences	in	the	way	precursor	cells	signal	to	each	other	during	the	vulva’s	growth	(Dawes	et	al.,	2017).	During	the	formation	of	the	nematode	vulva,	six	vulval	precursor	cells	(VPCs)	located	in	the	ventral	epidermis	of	the	worm	are	stimulated	by	another	cell	called	the	anchor	cell	located	just	dorsal	to	the	six	(Sherwood	and	Sternberg,	2003).		In	C.	
elegans,	during	the	L3	larval	stage,	the	anchor	cell	will	release	the	EGF	signal	through	LIN-3	and	cause	the	nearest	VPC	(P6.p)	to	adopt	the	primary	cell	fate	and	become	the	apex	of	the	vulva.		The	two	cells	adjacent	to	P6.p	will	take	on	a	
Figure	2:	Diagram	of	EGF	signal	transduction	in	nematodes.	
Figure	3:	Initial	signaling	in	the	development	of	the	vulva	
secondary	cell	fate	to	form	the	sides	of	the	vulva	and	the	other	three	VPCs	will	all	adopt	a	non-specialized	tertiary	fate	causing	fusion	with	the	epidermal	syncitium	(Wang	and	Sternberg,	2001).		Figure	3	gives	a	graphical	representation	of	the	process.				 In	both	these	species,	current	literature	indicates	that	the	specification	of	the	primary	and	secondary	fate	in	VPCs	comes	from	a	combination	of	sequential	and	morphogen-based	induction.		The	primary	cell	fate	is	determined	by	proximity	to	the	anchor	cell	EGF	signal	and	amount	of	signal	received	(Herman	and	Hedgecock,	1990).		Secondary	cell	fates	are	derived	from	a	combination	of	a	weaker	EGF	signal	and	an	inhibitory	signal	from	the	primary	cell	through	the	Notch	pathway	(Berset	et	al.,	2001).		Experiments	involving	ablation	of	the	anchor	cell	early	in	nematode	development	always	leads	to	a	vulvaless	phenotype	in	both	C.	elegans	and	C.	
briggsae	(Félix	2012).		In	C.	elegans,	the	adoption	of	the	primary	fate	by	P6.p	is	especially	dependent	on	the	EGF	signal;	later	in	vulval	development,	C.	elegans	VPCs	will	remain	undivided	and	unspecialized	if	the	EGF	anchor	cell	signal	is	eliminated	through	the	application	of	a	U0126	MEK	inhibitor	that	removes	signaling	from	the	EGF	pathway	(Dawes	et	al.,	2017).			Conversely,	C.	briggsae	nematodes	will	have	VPCs	P5.p-P7.p	adopt	secondary	cell	fates	when	the	U0126	is	applied,	indicating	sensitivity	in	the	absence	of	the	anchor	cell	EGF	signal.	(Dawes	et	al.,	2017).		This	indicates	a	major	difference	between	the	two	species	in	how	the	EGF	signaling	pathway	patterns	the	VPCs.		C.	briggsae	nematodes	may	retain	vulval	competence	through	a	variety	of	ways:	an	additional	signal	from	the	anchor	cell,	signals	from	other	surrounding	cells,	or	a	Notch	signal	coming	internally	from	P5.p-P7.p.		C.	elegans	nematodes	express	a	Cel-lip-1::GFP	transgene	(indicative	of	Notch	signaling)	only	in	P5.p	and	P7.p,	the	cells	that	typically	assume	a	secondary	fate	(Félix	2012).		C.	
briggsae	nematodes	express	the	same	reporter	in	P5.p-P7.p	normally,	suggesting	that	Notch	may	have	a	strong	role	in	providing	VPC	competence	in	C.	briggsae	(Félix	2012).			The	goal	of	this	project	was	to	further	analyze	this	variation	by	studying	the	effects	of	Notch	mutations	in	C.	briggase.		By	hyperactivating	and	destroying	the	function	of	the	LIN-12	receptor,	this	experiment	hoped	to	show	the	effects	of	a	constitutively	active	Notch	pathway	and	a	nonexistent	pathway.		If	worms	with	these	mutations	were	obtained,	MEK	inhibitor	U0126	would	be	applied	to	the	worms	to	then	see	the	effect	of	EGF	signaling	removal.		With	C.	briggsae,	it	was	
Figure	4:	Proposed	model	of	Notch-EGF	interaction	in	specifying	VPC	fate	
predicted	that	overexpressing	Notch	would	lead	to	VPCs	overpowering	the	EGF	signal	and	all	adopting	a	secondary	fate;	on	the	contrary,	a	lack	of	Notch	signaling	would	allow	an	EGF-driven	primary	fate	to	be	taken	on	by	all	the	VPCs.		U0126	would	likely	have	no	effect	on	constitutive	Notch	worms	and	would	probably	create	a	vulvaless	phenotype	in	worms	without	a	Notch	signal.				 To	generate	the	desired	mutations,	this	project	sought	to	apply	uniquely	devised	Co-CRISPR	strategies	to	induce	the	desired	mutations	in	C.	briggsae	nematodes.		A	clustered	regularly	interspersed	short	palindromic	repeats	(CRISPR)-Cas9	system	allows	the	targeting	of	a	specific	gene	and	the	ability	to	place	a	specific	mutation	or	indel	in	the	gene	(Ma	et	al.,	2014).		The	system	uses	a	Cas9	protein,	normally	involved	in	bacterial	defense	systems	against	viruses,	to	cut	at	a	particular	point	indicated	by	a	CRISPR	RNA.		This	model	has	been	adapted	for	use	in	C.	elegans	and	has	shown	promising	signs	of	effectiveness	(Paix	et	al.,	2015).		To	induce	a	mutation,	a	single	guide	RNA	(sgRNA)	must	be	created	first.		This	is	a	singular	large	strand	of	RNA	that	contains	a	tracrRNA	that	binds	the	Cas9	protein	and	the	CRISPR	RNA	(Zhang	et	al.,	2014).	The	sgRNA	needs	to	contain	a	20	base	pair	guide	sequence	at	the	5’	end	which	pairs	with	the	target	DNA	and	directs	the	Cas9	protein	to	cleave	at	a	certain	sequence.		Aside	from	the	guide	sequence,	Cas9	also	requires	a	three	base	pair	protospacer-adjacent	motif	(PAM)	located	next	to	the	guide	sequence	that	allows	Cas9	to	bind	(Zhang	et	al.,	2014).		In	this	experiment,	a	Cas9	protein	was	used	that	requires	a	PAM	of	NGG.					 Co-CRISPR	requires	the	creation	of	two	sgRNA	plasmids:	one	that	contains	an	sgRNA	targeting	a	gene	with	a	known	effect	and	an	sgRNA	containing	the	mutation	of	interest.		It	allows	a	mutation	with	unknown	effects	to	be	readily	identified	in	nematodes	by	association	with	another	successful	and	known	mutation	(Arribere	et	al.,	2014).		This	saves	large	amounts	of	time	in	post-injection	PCR	screening.		A	worm	showing	the	effects	of	the	known	sgRNA	mutation	likely	has	the	unknown	sgRNA	expressed	as	well.		In	CRISPR	the	primary	reason	causing	a	cloned	plasmid	to	not	express	is	the	lack	of	active	Cas9	machinery	in	the	oocyte.		Often,	as	long	as	the	cell	contains	active	Cas9,	both	sgRNAs	on	their	respective	plasmids	will	be	expressed	(Kim	et	al.,	2014).				 This	project	used	marker	alleles	of	genes	that	had	previously	been	characterized:	Cel-rol-6	(su1006),	Cel-dpy-10	(cn64),	and	Cel-sqt-1(e1350).		These	alleles	were	shown	to	be	easily	phenotypically	identifiable	in	a	Cas9	system	and	lead	to	the	isolation	of	affected	nematodes	in	only	a	few	generations	(Arribere	et	al.,	2014).			Each	gene	codes	for	a	cuticle	collagen,	and	a	change	from	an	arginine	to	cysteine	in	each	case	leads	the	mutation	in	rol-6	and	sqt-1	to	create	right	rollers	and	the	allele	in	dpy-10	to	cause	left	rollers	(Arribere	et	al.,	2014).		All	of	these	alleles	caused	dominant	mutations	as	well	leading	to	easier	screening.		In	addition,	the	mutant	phenotypes	were	distinct	from	null	mutations,	meaning	candidate	rollers	had	undergone	a	CRISPR	repair	through	homology	directed	repair,	rather	than	an	indel	caused	by	non-homologous	end-joining.		Previous	work	on	the	alleles	was	all	performed	in	C.	elegans,	so	the	associated	sgRNA	and	oligonucleotide	repair	templates	had	to	be	reproduced	using	the	C.	briggsae	genome.		Fortunately,	the	two	species	are	related	enough	that	the	specific	mutation	found	for	each	allele	could	still	be	nearly	exactly	replicated	in	C.	briggsae.			
	
Materials	and	Methods	
	
Strains	The	Bristol	N2	strain	was	used	in	experiments	performed	on	C.	elegans	and	the	strain	AF16	was	used	for	all	experiments	involving	C.	briggsae.		Both	were	grown	on	nematode	growth	medium	(NGM)	in	plates	containing	OP50	bacteria	(Brenner	1974).				
CRISPR	Methodology		As	described,	CRISPR	requires	the	use	of	sgRNAs,	an	expressed	Cas9	protein,	and	donor	repair	template.		For	transformation,	a	single-stranded	oligonucleotide	or	donor	plasmid	containing	a	repair	template	is	required;	this	experiment	used	the	oligonucleotide.		This	experiment	used	short-range	homology	directed	repair	to	create	point	mutations	to	cause	a	desired	phenotype.		An	ideal	repair	template	needed	to	be	less	than	approximately	100	base	pairs	(Dickinson	et	al.,	2013).		After	Cas9	cleaves	the	DNA	at	the	cut	site,	the	blunt	ends	are	trimmed	back	and	then	allow	the	donor	oligonucleotide	to	begin	repair	based	off	of	the	homologous	region.		Once	successfully	cloned,	the	modified	pDD162	was	injected	into	worms	along	with	a	GFP	marker.		The	plasmid	pDD162	contains	the	Cas9	coding	sequence	attached	to	the	gene	eef-1A’s	promoter	and	the	sgRNA	attached	to	a	universal	U6	promoter	allowing	expression	through	RNA	polymerase	III	(Dickinson	et	al.,	2013).		Follow-up	evaluation	was	then	performed	on	worms	manifesting	the	desired	phenotype.				
sgRNA	Creation	For	each	Co-CRISPR	marker	gene,	the	genome	location	of	the	C.	elegans	mutation	was	first	identified	in	the	C.	briggsae	genome.		The	species	are	close	enough	that	the	same	mutations	could	be	applied	to	C.	briggsae.		Next,	suitable	sgRNAs	were	found	using	the	site	http://crispr.mit.edu	(Hsu	et	al.,	2013).		The	site	provides	all	possible	guide	sequences	found	within	a	range	of	the	data	inputted	and	provides	statistics	on	each	comparing	the	specificity	and	likelihood	of	effectiveness.		The	tool	was	only	able	to	compare	against	the	C.	elegans	genome,	so	after	selection	of	an	sgRNA	each	was	compared	against	the	C.	briggsae	genome	to	ensure	no	unexpected	matches	in	other	genes.		Thus	sgRNAs	were	found	for	Cbr-rol-1,	Cbr-dpy-10,	Cbr-sqt-1,	a	predicted	constitutive	dominant	mutation	in	Cbr-lin-12,	and	a	predicted	loss-of-function	mutation	in	Cbr-lin-12	(Figure	5).		After	ordering,	each	sgRNA	was	placed	into	the	pDD162	plasmid.	The	type	of	Cas9	used	in	these	experiments	requires	a	guanine	before	the	20	base	pair	guide	sequence.		After	the	promoter,	pDD162	contains	this	guanine	and	is	the	optimal	plasmid	for	the	strain	of	Cas9	used.		Cloning	into	the	plasmid	began	with	overlap	extension	PCR,	where	varying	concentrations	of	marker	sgRNA	oligonucleotides	were	used	in	the	PCR	(10	ng/µl	and	40	ng/µl)	since	these	were	shown	to	previously	be	the	optimal	concentrations	(Arribere	et	al.,	2014).		Afterward,	DpnI	was	used	to	digest	away	any	original	methylated	plasmids	and	then	followed	up	with	a	ligation	to	attach	the	blunt	ends.		Plasmids	were	then	used	to	transform	DH5α	E.	coli	bacteria	and	positively	selected	for	through	carbenicillin	agar	plates.		Experimental	results	were	compared	against	control	
plates	that	contained	plasmids	that	underwent	the	initial	PCR	without	a	DNA	extension	enzyme.		Experimental	plates	that	showed	significantly	more	colonies	than	control	plates	had	colonies	cultured	and	plasmids	extracted	for	further	evaluation.		Potential	colonies	were	cultured	and	plasmids	were	recovered	for	verification	PCR	using	specific	primers	flanking	the	mutation	site	of	interest.		PCR	amplified	segments	were	tested	through	a	restriction	enzyme	digest	and	any	plasmids	with	positive	results	were	sequenced	to	ensure	the	presence	of	the	sgRNA	insert.			
	
Repair	
Oligonucleotide	
Creation	The	desired	mutations	for	each	sgRNA	to	create	were	all	point	mutations;	therefore,	the	repair	oligonucleotides	were	made	at	the	maximum	length	that	would	still	be	repaired	using	the	highly	efficient	short-range	homology	directed	repair	(100	bp).		Aside	from	the	point	mutation	to	alter	phenotype,	two	other	changes	had	to	be	incorporated	into	each	oligonucleotide:	ones	changing	the	PAM	site/multiple	points	in	the	cut	site	to	prevent	repeated	Cas9	cleavage	and	additional	ones	to	create	a	novel	restriction	enzyme	cut	site	for	easier	screening.		Figure	5	includes	the	modified	parts	of	the	repair	template.			
	
Verification	of	introduction	of	DNA	Changes	In	order	to	determine	if	DNA	changes	had	properly	been	installed	into	the	nematode	genome,	verification	primers	and	sequencing	primers	were	designed	as	well.	The	designed	repair	templates	had	alterations	placed	in	them	that	would	create	a	restriction	enzyme	cut	site	around	the	experimental	point	mutation.		These	verification	primers	amplified	a	region	in	the	DNA	~250	base	pairs	away	on	either	
Figure	5:	C.	briggsae	sgRNAs	developed	for	all	markers	and	Notch	mutations	
side	of	the	point	mutation.		When	cut	with	the	restriction	enzyme,	the	repaired	DNA	would	present	at	different	sizes	than	wild	type	DNA	because	of	the	added	(or	deleted)	cut	site.	Additionally,	sequencing	primers	that	could	read	internal	to	the	verification	primers	were	also	created	to	completely	verify	presence	of	the	repair	template	insertion.		Specific	sequences	of	primers	are	found	in	S3	and	S4.		
Injections	DNA	was	injected	into	the	germline	of	wild-type	animals	(C.	elegans	or	C.	briggsae)	following	standard	protocols	(Mello	et	al.,	1991).		For	every	individual	marker	sgRNA	designed,	an	initial	injection	was	performed	containing	sgRNA	at	a	concentration	of	50	ng/µl,	repair	oligonucleotide	at	20	ng/µl,	and	a	myo-2	GFP	marker	at	25	ng/µl.		The	GFP	marker	was	present	to	identify	successful	injection	of	the	mix	into	the	nematode	gonad.		For	Co-CRISPR,	the	same	concentrations	were	used	for	marker	sgRNA,	repair	oligonucleotide,	and	myo-2	GFP	marker	except	another	dose	of	experimental	sgRNA	and	repair	template	was	added.		In	these	mixes,	the	final	concentration	of	DNA	present	in	the	injection	mixture	was	165	ng/µl.			
	
Screening	F1	worms	that	exhibited	the	dominant	co-CRISPR	phenotype	(e.g.,	Rol)	were	selected	to	individual	plates	and	allowed	to	self-cross.	After	allowing	about	1	week	for	these	individual	nematodes	to	produce	a	subsequent	generation	and	clear	the	bacteria	from	the	plate,	worms	were	then	harvested	through	an	M9	washing	procedure,	and	frozen	at	-80C.		DNA	was	recovered	by	adding	worm	lysis	buffer	containing	proteinase	K	at	a	concentration	of	10	ng/mL	and	then	incubating	the	tube	at	60˚C	for	one	hour	and	then	inactivated	the	reaction	enzyme	through	a	fifteen	minute	95˚C	heating	period.		Afterward,	the	extracted	experimental	DNA	was	put	through	PCR	along	with	a	positive	control	wild-type	DNA.		Amplified	DNA	was	digested	with	their	respective	restriction	enzymes	for	four	hours	along	with	undigested	controls	and	run	on	a	2%	agarose	gel	for	size	comparison.		Any	experimental	sample	that	displayed	at	the	correct	expected	size	was	further	purified	using	the	PCR	nucleic	acid	purification	kit	and	then	put	in	for	sequencing	using	the	gene’s	respective	sequencing	primer.		
Results			 	
Verification	of	the	co-CRISPR	method	using	C.	elegans	Before	any	of	the	C.	briggsae	CRISPR	plasmids	were	designed,	C.	elegans	Cas9	systems	were	tested	to	see	the	efficacy	of	Cas9	in	nematodes	firsthand.		Identical	sgRNAs,	repair	templates,	verification	primers,	and	sequencing	primers	from	the	paper	Arribere	2014	were	cloned	into	pDD162	and	injected	into	worms	(Figure	S1,	S2,	S3,	S4).		All	candidate	marker	gene,	rol-6,	dpy-10,	and	sqt-1,	were	put	through	an	overlap	extension	PCR,	ligation,	and	transformation	process	similar	to	that	described	in	the	methods.		Fragments	were	then	digested	using	a	specific	enzyme	that	showed	varying	results	depending	on	successful	insertion	of	the	sgRNA.		Successful	results	were	indicated	by	gels	that	cut	at	expected	sizes	against	wild	type	
genomic	controls.		In	elegans,	expected	positive	gel	results	were	obtained	for	rol-6	and	dpy-10.		Sqt-1	never	displayed	a	significantly	greater	amount	of	colonies	when	compared	to	the	control	so	it	was	not	further	analyzed	as	a	candidate.		Each	marker	gene	was	individually	injected	into	
elegans	worms	evaluate	their	effectiveness.		F1	worms	were	self-crossed	and	the	progeny’s	DNA	was	harvested	after	one	week.		DNA	was	extracted	and	checked	for	mutants	after	this	through	sequencing.		Often,	negative	results	would	not	display	a	wild-type	conformation,	but	a	deletion	around	the	site	of	interest	or	unexpected	mutation	(Figure	7).		It	is	possible	that	Cas9	did	cut	in	these	cases	but	the	repair	template	was	not	used	in	repair,	leaving	the	cell	to	use	nonhomologous	end-joining	to	repair	the	double-stranded	break.		Another	option	is	that	the	repair	oligonucleotide	may	not	have	been	present	in	the	cell	and	segregated	independently	of	the	sgRNA-containing	plasmid.		Regardless,	C.	elegans	rol-6	and	dpy-10	marker	genes	were	shown	to	be	competent	for	further	analysis	using	Co-CRISPR.												 		
Development	of	a	co-CRISPR	method	for	C.	briggsae	For	the	C.	briggsae	Cas9	systems,	the	marker	gene	mutations	injected	into	the	nematodes	also	had	success	(materials	listed	in	S1,	S2,	S3,	and	S4).		The	best	results	came	from	the	Cbr-rol-6	marker.		First	generation	rollers	were	found	to	be	heterozygous	for	the	experimental	repair	template	and	manifested	the	expected	right-rolling	phenotype.		These	results	were	verified	
Figure	6:	(top)	Gel	showing	evidence	of	successful	dpy-10	repair	template	incorporation	into	N2	nematodes.	Wild	type	expected	cut	size	was	631	base	pairs	and	368	and	263	pairs	for	mutant	(bottom)	Example	of	sequencing	results	from	candidate	dpy-10	mutated	N2	nematodes.		Screens	1	and	2	indicate	success	of	transformation	and	3	is	a	case	of	failed	cutting.			
Figure	7:	(top)	Gel	evidence	of	rol-6	transformation	of	AF16	
briggsae	nematodes.	Wild	type	expected	cut	size	was	528	base	pairs	and	373and	155	pairs	for	mutant	(bottom)		Sequencing	results	showing	successful	mutation	of	worms.		Screens	1	and	2	indicate	perfect	repairs	and	screen	3	a	case	of	aberrant	CRISPR	repair.	
Wild	Type	DNA 
Experimental	DNA 
Wild	Type	DNA 
Experimental	DNA 
through	restriction	digests	and	sequencing	(Figure	7).		The	other	marker	genes	dpy-
10	and	sqt-1	had	similar	issues	to	the	elegans	markers;	some	candidates	contained	nonsense	inserts	around	the	cut	site	or	simply	had	a	portion	of	the	targeted	area	deleted.		Despite	the	success	with	single	marker	injection,	nematodes	co-injected	with	either	lin-12	gain	or	loss	of	function	sgRNAs	and	repair	templates	as	well	as	a	
Cbr-rol-6	marker	failed	to	display	any	phenotype	that	was	detectable	through	microscopy	and	any	candidates	genotyped	did	not	contain	the	experimental	repair	template	in	the	genome	(Figure	8).			 rol-6	phenotype	 lin-12	loss	evidence	 lin-12	g.o.f.	evidence	
lin-12	co-CRISPR	injection	success	rate	 9/9	(100%)	 0/4	(0%)	 0/5	(0%)	 		 				
Discussion		
Development	of	a	co-CRISPR	method	for	C.	briggsae	The	C.	elegans	plasmids	used	in	this	experiment	where	already	designed	and	investigated	by	a	previous	study	(Arribere	et	al.,	2014)	but	were	shown	to	be	highly	effective	as	Co-CRISPR	markers	when	injected	firsthand.		Markers	in	C.	briggsae	were	not	as	successful,	but	Cbr-rol-6	was	still	found	to	be	a	useful	marker.		Although	the	lin-12	experiments	are	to	this	point	unsuccessful,	this	plasmid	can	still	be	used	for	many	other	Co-CRISPR	experiments	to	aid	in	identifying	unknown	phenotypes.			Additional	markers	can	sill	be	tested	in	C.	briggsae,	many	genes	leading	to	an	uncoordinated	phenotype	have	potential	as	markers	as	well.		
Possible	Causes	of	lin-12	negative	Results	For	lin-12	mutations	the	lack	of	results	could	have	stemmed	from	a	multitude	of	issues.		First,	the	previously	described	cases	could	have	occurred	where	Cas9	fails	to	cut	properly	or	the	CRISPR	materials	for	the	experimental	lin-12	alterations	failed	to	segregate	to	the	same	oocyte	as	the	marker	gene	CRISPR	materials.		Previous	studies	applying	CRISPR	to	C.	elegans	have	reported	varying	rates	of	success	ranging	from	1-16%	of	F1	progeny	showing	successful	HDR	mutation	(Dickinson	et	al.,	2013;	Arribere	et	al.,	2014;	Kim	et	al.,	2013).		The	dearth	of	lin-12	candidates	may	arise	from	too	little	screening.		At	this	point,	there	is	some	luck	involved	in	the	CRISPR	process,	and	so	far	injections	and	screening	may	have	simply	not	provided	any	successful	candidates.			Co-CRISPR	undeniably	increases	the	rate	of	detection	of	cutting	events	when	searching	for	NHEJ	events,	but	it	is	not	as	effective	when	searching	for	HDR	events	(Kim	et	al.,	2013).		The	Cas9-sgRNA	complexes	are	assembled	in	the	germline	cytoplasm.		After	this,	the	CRISPR	machinery	may	be	
Figure	8:	Five	nematodes	from	Cbr-lin-12	g.o.f.	and	Cbr-rol-6	co-injections	displayed	the	rolling	marker	phenotype	and	had	lines	made	from	them	for	further	evaluation.			Four	Cbr-lin-12	l.o.f.	co-injections	were	examined	as	well	but	no	evidence	of	lin-12	mutant	phenotypes	was	confirmed.	
placed	into	oocytes	independently	of	the	repair	templates.		Cas9	also	has	a	relatively	high	tolerance	for	mismatches.		Studies	have	found	that	this	endonuclease	can	still	cut	at	a	site	containing	as	many	as	six	mismatches	in	the	cut	site	(Jinek	et	al.,	2012).		Despite	induced	mutations	in	the	cut	sites	and	PAM	sequences,	there	is	still	a	chance	that	Cas9	has	been	cutting	off	target	and	altering	the	genome	in	irreparable	ways.		To	add	to	this,	the	briggsae	genome	is	sometimes	not	fully	annotated	and	constructed.		Even	though	each	guide	RNA	sequence	was	tested	against	the	genome	using	BLAST,	sites	that	are	not	fully	put	together	could	have	matched	to	the	guide	and	allowed	off	target	cuts.		Additional	explanations	include	issues	with	the	markers	and	guide	RNAs	used.		The	rol-6	marker	had	previously	been	tested	in	C.	elegans	and	had	shown	success	firsthand	in	this	lab,	but	still	remains	somewhat	unknown	in	C.	briggsae.		Other	studies	using	Co-CRISPR	call	for	a	marker	that	has	an	intermediate	amount	of	effectiveness.		A	marker	that	works	too	well	could	show	a	large	proportion	of	false	positives	where	the	marker	is	successful	while	the	experimental	CRISPR	is	not.		Conversely,	a	marker	that	is	too	ineffective	might	show	very	randomly	and	again	not	be	a	good	indicator	for	lin-12	mutations,	since	the	marker	would	rarely	show	itself	(Kane	et	al.,	2016).		For	Cas9,	the	optimal	guide	RNA	contains	a	dual	guanine	site	previous	to	the	PAM	(Dickinson	et	al.,	2013).		In	the	case	of	the	lin-12	gain	of	function	sgRNA	designed,	these	guanines	were	not	present.			A	better	sgRNA	that	does	contain	this	could	potentially	increase	the	rate	of	cutting.		Finally,	the	concentration	of	pDD162	injected	may	have	an	effect	on	the	efficiency.		The	plasmid	was	injected	at	10	ng/mL	and	40	ng/mL,	both	of	which	were	shown	to	have	high	success	previously	(Dickinson	et	al.,	2013).		Other	concentrations	could	be	tried	to	find	the	optimal	condition.	For	the	lin-12	gain	of	function	allele,	the	n137	mutation	has	been	highly	characterized	in	C.	elegans	and	is	known	to	cause	a	constitutively	expressing	Notch	pathway	through	alteration	of	the	LIN-12	receptor	(Greenwald	and	Seydoux,	1990).		The	mutation	involves	a	missense	point	mutation	to	create	the	effect.		In	C.	briggsae,	it	is	hypothetically	possible	to	induce	the	same	effect	using	the	same	mutation	since	the	sequence	around	the	point	of	interest	are	directly	orthologous	between	C.	
elegans	and	C.	briggsae	for	hundreds	of	base	pairs;	however,	this	mutation	has	not	been	as	well	defined	in	briggsae	and	may	not	have	the	same	effect.		Similarly,	the	attempted	loss	of	function	alteration	was	a	completely	novel	nonsense	mutation	that	had	not	been	characterized	in	elegans	or	briggsae.		The	change	would	have	ideally	truncated	the	LIN-12	protein	severely	and	prevented	transmission	of	any	signal.		Additional	issues	regarding	functional	differences	in	lin-12	between	the	species	might	have	prevented	the	manifestation	of	any	mutant	phenotype.		C.	
briggsae	contains	a	highly	identical	paralog	to	lin-12	(96%	identical	at	the	nucleotide	level)	that	could	have	evaded	conversion	by	the	loss	of	function	repair	template	and	compensate	for	the	loss	of	the	initially	targeted	paralog	(Rudel	and	Kimble,	2002).			However,	PCR	screening	would	have	likely	still	detected	mutant	alleles	in	nematodes	displaying	no	phenotype.	A	final	reason	that	could	point	to	lack	of	experimental	lin-12	candidates	could	be	the	promoters	used	to	express	the	sgRNA	and	the	Cas9	protein.		Plasmids	utilizing	C.	elegans	promoters	driving	expression	of	sgRNA	and	Cas9	were	used	for	
the	C.	briggsae	studies.			The	U6	and	eft-3	promoter	are	expressed	practically	universally	in	the	nematode,	but	it	is	not	known	if	there	might	be	differences	between	the	C.	elegans	and	the	C.	briggsae	promoters.		In	C.	elegans,	a	lin-12	paralog,	
glp-1,	is	able	to	take	over	the	function	of	lin-12	in	all	cells	of	the	worm	except	those	involved	in	the	formation	of	the	vulva	(Lambie	and	Kimble,	1991).		The	relationship	between	glp-1	and	lin-12	is	less	defined	in	briggsae,	but	total	loss	of	lin-12	does	lead	to	larval	lethality	(Rudel	and	Kimble,	2002).		The	two	promoters	used	may	have	overexpressed	and	underexpressed	lin-12	throughout	the	entire	nematode	and	thus	led	to	lethality.		
Future	Experimental	Changes		 Two	aspects	of	the	CRISPR	techniques	used	stand	out	as	candidates	for	experimental	alterations:	the	plasmid	and	guide	RNA	chosen	as	well	as	the	types	of	mutation	aimed	for	with	lin-12.				 The	pDD162	plasmid	is	effective	in	CRISPR	in	elegans,	but	may	not	be	as	useful	in	briggsae	due	to	the	promoters	that	it	contains.		The	U6	and	eft-3	promoter	are	both	derived	from	C.	elegans.		A	possible	solution	might	come	from	cloning	in	promoters	more	specific	to	C.	briggsae	(either	from	orthologous	or	novel	genes).	Another	possible	change	could	come	from	more	specific	guide	RNAs	for	the	lin-12	sequences	that	contain	guanines	prior	to	the	PAM	sequence.		 One	other	possibility	for	increasing	efficiency	could	come	from	changing	the	Cas9	endonuclease	so	that	it	operates	as	a	nickase.		Normally,	Cas9	contains	two	nuclease	domains	that	cleave	the	complementary	and	non-complementary	DNA	site	(Jinek	et	al.,	2012).		If	this	occurs	then	the	DNA	will	be	repaired	by	the	highly	efficient	base	excision	repair	system	(Dianov	and	Hubscher,	2013).			If	a	repair	template	is	provided,	then	HDR	has	been	shown	to	be	preferred	over	NHEJ	(Cong	et	al.,	2013).			This	method	would	require	the	development	of	two	plasmids	that	would	both	have	to	segregate	to	the	same	oocyte.		As	prior	mentioned,	this	already	can	be	a	reason	for	low	cutting	efficiency.		 Finally,	the	lin-12	mutations	themselves	could	be	changed.		The	desired	gain	of	function	mutation	simply	may	not	create	the	same	effect	in	C.	briggsae	that	is	seen	in	C.	elegans.		Other	comparable	and	characterized	mutations	identified	in	C.	elegans	could	be	tried	in	C.	briggsae	as	n137	was,	but	there	is	still	no	guarantee	of	success.		As	for	the	loss	of	function	mutation,	the	goal	of	a	nonsense	point	mutation	may	be	simplified	by	aiming	for	NHEJ	repair	after	cutting.		This	type	of	repair	has	a	higher	success	rate	(Dickinson	et	al.,	2013)	and	would	still	destroy	the	gene	if	used	to	fix	the	double-stranded	break.					 	
	
	
	
	
	
	
Supplementary	Data	
	
Experimental	sgRNAs	(S1)	Single-guide	RNAs	contained	an	NGG	PAM	site	and	optimally	had	a	guanine	before	the	PAM	site.		All	marker	sgRNAs	had	at	least	a	3	base	pair	difference	between	the	target	sequence	and	any	other	genome	locus.		Each	sgRNA	also	included	the	desired	restriction	enzyme	cut	site.		Highlighted	text	indicates	a	PAM	site.		
Cel-rol-6	GTGAGACGTCAACAATATGG	AGG		
Cel-dpy-10	GCTACCATAGGCACCACGAG	CGG			
Cel-sqt-1	ATGTGGAGTTGGGGTAGCGT	TGG	(forward)	TGGAAGGACATAGTTGTCAT	CGG	(reverse)		
Cbr-rol-6	GTGAGACGTCAACAATACGGAGG		
Cbr-dpy-10	TCCGGAAATCGTACGGCTCGTGG		
Cbr-sqt-1	CGTTGGTTTCTTCATACTGACGG		
Cbr-lin-12	constitutive	TCCTTTCTTGGCAAGTCTTGCGG		
Cbr-lin-12	l.o.f	TGATTGGAATCAAAAGTCAATGG		The	constitutive	mutation	was	based	off	the	n137	allele	found	in	C.	elegans.		This	is	a	missense	mutation	that	manifests	a	very	strong	gain	of	function	phenotype.		The	C.	
briggsae	genome	matched	the	C.	elegans	exon	exactly	around	the	point	mutation	so	this	was	used	as	the	basis	for	its	creation.		The	loss	of	function	sgRNA	was	an	induced	nonsense	mutation	in	exon	2	of	lin-12.		All	elegans	sgRNAs	for	marker	genes	were	taken	from	Arribere,	2014.				
	
	
Repair	Oligonucleotides	(S2)	Repair	templates	expanded	100	base	pairs	around	the	sgRNA	to	ensure	the	more	efficient	short-range	HDR	was	used	for	repair.		Yellow	highlighting	indicates	a	mutation	of	interest	and	green	signifies	mutations	to	destroy	the	PAM	site	and	create	a	novel	restriction	enzyme	cut	site.		All	mutations	beside	the	mutation	of	interest	caused	silent	mutations.		C.	elegans	repair	oligonucleotides	were	taken	from	Arribere,	2014.		
Cel-rol-6	TGTGGGTTGATATGGTTAAACTTGGAGCAGGAACCGCTTCCAACCGTGTGCGCTGCCAACAATATGGAGGATATGGAGCCACTGGTGTTCAGCCACCAGCACCAAC		-	BbvI	cut	site	introduced		
Cel-dpy-10	CACTTGAACTTCAATACGGCAAGATGAGAATGACTGGAAACCGTACCGCATGCGGTGCCTATGG	TAGCGGAGCTTCACATGGCTTCAGACCAACAGCCTAT		-	SphI	cut	site	introduced		
Cel-sqt-1	GGGGATCCATCAGCATGTGGAGTTGGGGTAGCGTTCGTCTCTTCATATTGGCAGCGGACACGTTGCTAGATCTTCCTATAACCACTATGTCCTTCCACAATCC		-	BbvI	cut	site	introduced		
Cbr-rol-6	GGGTTGATATGGTCAAGCTTGGAGCTGGAACCGCTTCAAACAGAGTGAGATGCCAACAATACGGTGGATACGGAGCCAGTGGAGTTCAGCCACCAGCACCA	-	XcmI	cut	site	introduced		
Cbr-dpy-10	CTCTAGAACTTCAATTCGGCAAAATGAAACTATCCGGAAATCGTACGGCATGCGGTGCTTATGGAAGCGGAGCTTCCCATGGATTCAGACCAACTGCTTAT	-	SphI	cut	site	introduced		
Cbr-sqt-1	GATTGTGGAAGGATATTGTTGTGATTGGAAGAAACAGCAAGCGTGTACGGTGTCAGTATGAAGAAACCAACGCCACCCCAACCCCACACGCTGATGGATCC	-	HpyCH4III	cut	site	introduced			
Cbr-lin-12	constitutive		CAATGCTAAATGCCTATACAAAGACTCTCAAACTGTTGTCGATTTGATCTTCTCAGGACTTGCCAAGAAAGGAATCAACTCTTTTGGTATCCCGATTTCAG	-	DdeI	cut	site	introduced		
Cbr-lin-12	l.o.f.	CGGCTCCTACGGTTCATTTTGCGAGAAAAGCTGCCCGTAGACTTTTGATTCCAATCAAAAATGTGTCTACAACGAAGAGAATCAAGCAACATTATGTGTT	-	BsexI	cut	site	introduced			
Verification	Primers	(S3)	Primers	surrounded	the	mutation	of	interest	and	allowed	mutation	insert	to	be	determined	by	digests	that	would	cut	the	experimental	but	not	the	wild	type.		
Elegans	primers	were	taken	from	Arribere,	2014.		
Cel-rol-6	-5’	to	3’	forward		GCCATTGTATTTTCTGGAGCCAC		-3’	to	5’	reverse	CTCCACGTGGTCCTCCTCCATTC		Cut	size	wild	type:	436	bp	Cut	size	experimental:	235	and	201	bp		
Cel-dpy-10	-5’	to	3’	forward	GTCAGATGATCTACCGGTGTGTCAC		-3’	to	5’	reverse		GTCTCTCCTGGTGCTCCGTCTTCAC		Cut	size	wild	type:	631	bp	Cut	size	experimental:	368	and	263	bp		
Cel-sqt-1	-5’	to	3’	forward	GCGTCGCGTCCCTTCTCTCCTG		-3’	to	5’	reverse	ACATCCGTACTCCTTATCTCCCG		Cut	size	wild	type:	981	bp	Cut	size	experimental:	491	and	491	bp		
Cbr-rol-6	-	5’	to	3’	forward	 	 	 	 	 	GAATGAGCTGGATGCGGAAATCG	 	 	-3’	to	5’	reverse	 	 	TTGTGGGCATGTGAAGCAGC	 	Cut	size	wild	type:	528	bp	Cut	size	experimental:	373	and	155	bp	
	
Cbr-dpy-10	-	5’	to	3’	forward	 	 	 	 	 								TGTTGACAGAGAAATGGCTTATTGC		-	3’	to	5’	reverse	 	 	 	 	 									TTTGGAGTGGTTCCTGGCATTC		Cut	size	wild	type:	343	bp	Cut	size	experimental:	206	and	137	bp		
Cbr-sqt-1	-	5’	to	3’	forward	 	 	 	 	100	GGATTCAGAGAGCAACTCGACAC		-	3’	to	5’	reverse	 	 	 	 	 	567	TCCTTGTGGGCAAGTGAAGC	 	Cut	size	wild	type:	567	bp	Cut	size	experimental:	432	and	144	bp		
Cbr-lin-12	constitutive	-	5'	to	3’	forward	 	CGTGGAAGCCTCTCCAGAATATC	-	3’	to	5’	reverse	 	 	 	 	 	 	GTCCAAACTGGTGCATTGATAATCC		Cut	size	wild	type:	1927	and	385bp	Cut	size	experimental:	1729,	385,	and	198	bp	-	5’	to	3’	forward	GAAATGGATGTGAGAAATTAACAGAAC		-	3’	to	5’	reverse	GTCCAAACTGGTGCATTGATAATCC		Cut	size	wild	type:	366	bp	Cut	size	experimental:	198	and	169	bp		
Cbr-lin-12	l.o.f.	-	5’	to	3’	forward	 	CCCTTTACTCCAAATTCCCGTCTTC		-	3’	to	5’	reverse	ATTCAATTTCTGCGTTCTACGGTG		Cut	size	wild	type:	791	and	669	bp	Cut	size	experimental:	791,	410,	and	259	bp		The	lin-12	constitutive	verification	primers	had	two	forward	primers:	one	found	about	2	kb	back	in	the	gene	and	one	that	was	much	closer	to	the	mutation	of	interest.		These	primers	were	designed	to	avoid	a	paralog	of	lin-12	in	the	briggsae	genome	that	possesses	a	near	identical	sequence.		The	far	primer	was	specific	only	to	the	CBG06829	gene	of	interest	in	this	experiment	while	the	closer	forward	primer	contained	a	one	base	pair	difference	between	CBG06829	and	the	paralog	(indicated	by	the	green	highlighted	text).	
	
Sequencing	Primers	(S4)	
Elegans		primers	were	taken	from	Arribere,	2014.		
Cel-rol-6	R	primer	CCACCTCCTGGGAACTTTGGTTG		Found	82	base	pairs	downstream	from	the	end	of	the	repair	template.		
Cel-dpy-10	F	primer	TGTCTGTGTTGCTCTCCCAATTATG		Found	124	base	pairs	upstream	from	the	start	of	the	repair	template.		
pDD162	R	sequencing		CCATTCGCCATTCAGGCTGC	Found	116	base	pairs	downstream	from	the	expected	sgRNA	insert	site	in	pDD162.		
Cbr-rol-6	primer	CCACCTCCTGGGAACTTTGGTTG	Found	82	base	pairs	downstream	from	the	end	of	the	repair	template.										 																	
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